Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy?

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Cosar, Rusen ^a   Uzal, Cem ^a   Tokatli, Fusun ^b   Denizli, Bengu ^a   Saynak, Mert ^a   Turan, Nesrin ^a   Uzunoglu, Sernaz ^a   Ozen, Alaattin ^a   Sezer, Atakan ^a   Ibis, Kamuran ^a   Uregen, Burcu ^a   Yurut Caloglu, Vuslat ^a   Kocak, Zafer ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b Medicana International Istanbul   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; MASTECTOMY; MENOPAUSE; MORBIDITY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SYSTEMIC THERAPY; TUMOR VOLUME; ADJUVANT THERAPY; AXILLA; BREAST TUMOR; CARCINOMA; EVALUATION; FEMALE; FOLLOW UP; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; SURVIVAL; TIME; TUMOR RECURRENCE; UTILIZATION REVIEW;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79953086351     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-28     Document Type: Article

References (26)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365(9472):1687-717. 10.1016/S0140-6736(05)66544-0, 15894097, Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
2. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007, 84:102-103. 10.1016/j.radonc.2007.05.011, 17561296.
3. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997, 337:949-955. 10.1056/NEJM199710023371401, 9395428.
4. Overgaard M, Christensen JJ, Johansen H, et al. Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990, 19:1121-1124. 10.1016/0360-3016(90)90214-5, 2254100.
5. Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001, 93:979-989. 10.1093/jnci/93.13.979, 11438563.
6. Kunkler IH, Canney P, van TG, et al. Elucidating the role of chest wall irradiation in intermediate risk breast cancer: The MRC/EORTC SUPREMO trial. Clin Oncol (R Coll Radiol) 2008, 20:31-34.
7. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005, 97:116-126. 10.1093/jnci/djh297, 15657341.
8. Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus Statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 1999, 44:989-990. 10.1016/S0360-3016(99)00096-6, 10421530.
9. Recht A, Edge SB, Solin LJ, et al. American Society of Clinical Oncology. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19:1539-1569.
10. Recht A, Bartelink H, Fourquet A, et al. Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol 1998, 16:886-2889.
11. Truong PT, Berthlet E, Lee J et A. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005, 103:2006-2014. 10.1002/cncr.20969, 15812825.
12. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004, 70:225-230. 10.1016/j.radonc.2003.10.015, 15064006.
13. Van der Wal BCH, Butzelaar RMJM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in Stage I and II breast cancer. Eur J Surg Oncol 2002, 28:481-489. 10.1053/ejso.2002.1239, 12217299.
14. Megale Costa LJ, Soares HP, Gaspar HA, et al. Ratio between positive lymph nodes and total dissected axillary lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol 2004, 27:304-306. 10.1097/01.COC.0000071941.70772.DC, 15170153.
15. Truong PT, Olivotto IA, Kader HA, et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2005, 61:1337-1347. 10.1016/j.ijrobp.2004.08.009, 15817335.
16. Russell NS, Kunkler IH, Tienhoven G, Canney PA, Thomas J, Bartlett J, et al. Postmastectomy Radiotherapy: Will the Selective Use of Postmastectomy Radiotherapy Study End the Debate?. J Clin Oncol 2009, 27(6):996-997. 10.1200/JCO.2008.18.7062, 19164209.
17. Arriagada R, Lê MG. Number of positive axillary lymph nodes and post-mastectomy radiotherapy effectin breast cancer patients. Radiother Oncol 2007, 84(1):102-103. 10.1016/j.radonc.2007.05.011, 17561296.
18. Cheng SH, Horng CF, West M, et al. Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol 2006, 24:4594-602. 10.1200/JCO.2005.02.5676, 17008701.
19. Val G, Marivic L, Anthony K, John S, Langlands AO. Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective. J Natl Cancer Inst 2006, 98(1):26-38. 10.1093/jnci/djj002, 16391369.
20. Giardona SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005, 97:419-424. 10.1093/jnci/dji067, 1853253, 15770005.
21. Rutqvist LE, Rose C, Cavallin-Stahl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 2003, 42:532-545. 10.1080/02841860310014444, 14596511.
22. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link. Radiother Oncol 2000, 55:263-272. 10.1016/S0167-8140(00)00204-8, 10869741.
23. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000, 18:1220-1229.
24. Sotiriou C, Wirapati P, Loi S, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006, 98:262-272. 10.1093/jnci/djj052, 16478745.
25. Kreike B, Halfwerk H, Kristel P, et al. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy. Clin Cancer Res 2006, 12:5705-5712. 10.1158/1078-0432.CCR-06-0805, 17020974.
26. Fisher B, Wolmark N, Redmond C, et al. Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 1981, 48:1863-1872. 10.1002/1097-0142(19811015)48:8<1863::AID-CNCR2820480825>3.0.CO;2-U, 7284980.